Scientists create custom cancer vaccine from Patients' own cells
NCT ID NCT00458536
Summary
This study tested a personalized vaccine approach for advanced kidney cancer. Researchers created vaccines by combining patients' own cancer cells with their immune cells, then giving these back as injections. The main goals were to check if this approach was safe and to see if it could stimulate the immune system to fight cancer. The study involved 38 participants with stage IV kidney cancer who hadn't received prior chemotherapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
Conditions
Explore the condition pages connected to this study.